HemaSphere (Jun 2022)

P719: EFFICACY AND SAFETY OF BOSUTINIB IN LATER-LINE PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A SUB-ANALYSIS FROM THE PHASE 4 BYOND TRIAL

  • C. Gambacorti-Passerini,
  • T. H. Brümmendorf,
  • T. Ernst,
  • E. Leip,
  • S. Purcell,
  • A. Viqueira,
  • F. J. Giles,
  • G. Rosti,
  • A. Hochhaus

DOI
https://doi.org/10.1097/01.HS9.0000845760.12943.c0
Journal volume & issue
Vol. 6
pp. 614 – 615

Abstract

Read online

No abstracts available.